Evotec SE (EVO) Cash from Investing Activities (2009 - 2026)
Evotec SE's (EVO) quarterly Cash from Investing Activities came in at -$14.6 million in Q1 2026, up 35.95% year-over-year from -$10.7 million in Q1 2025, and up 71.28% quarter-over-quarter from -$50.7 million in Q4 2025.
Analysis
Evotec SE (EVO) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Cash from Investing Activities across 9 years of filings, most recently posting -$14.6 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 35.95% year-over-year to -$14.6 million; the TTM figure through Mar 2026 stood at -$98.6 million (down 47.54% YoY), while the FY2025 annual figure was $193.9 million, up 351.62% from the prior year.
- Cash from Investing Activities came in at -$14.6 million for Q1 2026 at Evotec SE, up from -$50.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $208.1 million in Q3 2022 to a low of -$420.7 million in Q4 2022.
- Average Cash from Investing Activities over 5 years is -$39.9 million, with a median of -$26.7 million recorded in 2025.
- The largest YoY upside for Cash from Investing Activities was 250.99% in 2022 against a maximum downside of 191439.37% in 2022.
- Over 5 years, Cash from Investing Activities stood at -$420.7 million in 2022, then jumped by 92.33% to -$32.3 million in 2023, then soared by 156.01% to $18.1 million in 2024, then tumbled by 380.36% to -$50.7 million in 2025, then surged by 71.28% to -$14.6 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$14.6 million in Q1 2026, -$50.7 million in Q4 2025, and -$8.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -381.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -23.89 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -108.34 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 28.10 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -7.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 11.09 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -55,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -55,941.69 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -14.56 Mn |
| Dec 31, 2025 | -50.69 Mn |
| Sep 30, 2025 | -8.47 Mn |
| Jun 30, 2025 | -24.84 Mn |
| Mar 31, 2025 | -22.73 Mn |
| Dec 31, 2024 | 18.08 Mn |
| Sep 30, 2024 | -28.46 Mn |
| Jun 30, 2024 | -33.69 Mn |
| Mar 31, 2024 | -33.58 Mn |
| Dec 31, 2023 | -32.28 Mn |
| Jun 30, 2023 | 26.29 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | -420.71 Mn |
| Sep 30, 2022 | 208.13 Mn |
| Jun 30, 2022 | -118.58 Mn |
| Mar 31, 2022 | -107.44 Mn |
| Dec 31, 2021 | -445.62 Mn |
| Sep 30, 2021 | 59.30 Mn |
| Jun 30, 2021 | 116.22 Mn |
| Mar 31, 2021 | -56,094.80 |